Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy.
about
How does the efficacy and safety of Oralair(®) compare to other products on the market?Critical appraisal of Timothy grass pollen extract GRAZAX in the management of allergic rhinitis.Treatment of congestion in upper respiratory diseases.Towards a vaccine for chronic obstructive pulmonary disease.Immunotherapy for house dust mite sensitivity: where are the knowledge gaps?Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment.Treatment of grass pollen allergy: focus on a standardized grass allergen extract - Grazax®.The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children."The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis".The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient surveySuppression of allergic airway inflammation and IgE responses by a class I restricted allergen peptide vaccine.Allergen immunotherapy for allergic respiratory diseasesSafety and tolerability of an intra-seasonal initiation of the SQ-standardised grass allergy immunotherapy tablet: a non-interventional observational study investigating the feasibility during routine administration.A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study.Clinical management, expectations, and satisfaction of patients with moderate to severe allergic rhinoconjunctivitis treated with SQ-standardized grass-allergen tablet under routine clinical practice conditions in SpainClinical immunology review series: an approach to desensitization.How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.Mechanisms of immunotherapy to aeroallergens.Sublingual immunotherapy for allergic rhinitis and conjunctivitis.Selection of patients for sublingual versus subcutaneous immunotherapy.Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.Updating the role played by immunotherapy for allergic rhinitis: meta-analysis.Immunotherapy for allergic rhinitis.Conference Scene: novelties in immunotherapy.Negative clinical results from a randomised, double-blind, placebo-controlled trial evaluating the efficacy of two doses of immunologically enhanced, grass subcutaneous immunotherapy despite dose-dependent immunological response.Sub-lingual immunotherapy: world allergy organization position paper 2009.Characteristics and trends of selected pollen seasons recorded in Parma (Northern Italy) from 1994 to 2011Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy
P2860
Q26745596-41543F99-C38C-40A7-A36E-D011D8E01E76Q26775905-5B8C796E-EFBA-4ED9-B755-FBBF69F55DA5Q30481520-78EC3BA4-6697-481F-8D2F-CED5295EFF59Q34257400-795F3008-DCA1-4A8D-9356-4149D8B0D635Q34445398-FAF3E3A8-44D1-458C-9B26-AE50566F33BDQ34522246-21D7684B-8943-4357-865A-37B7A9D4FEB9Q34606056-5F33EEBB-7EBA-4A4D-BAA2-7D01165D00CAQ35078784-98EB77C1-D366-4D51-83CB-355A4407ADEEQ35564301-EBB9F68B-E1D5-4C0D-8CD8-0414930379ECQ35645654-1F4546B3-4736-445D-B826-206D08F19B10Q36064566-623D3877-3C36-47B4-9864-8D9792068F63Q36864947-C656CE95-49D5-42CA-BD1D-14CD9425C84CQ37177099-DB97A75E-A1E0-4E33-89A6-BB738FDADE2DQ37325838-7A83F90F-3AD2-44AE-B658-6A7FB1F34B8CQ37584828-0A857854-2C8F-42AB-8AE1-A973352E878CQ37822834-76161CD8-636F-48FE-931A-BC70BC4630AFQ37865584-DB5538E3-8906-48DA-84C2-6B6DD328C367Q37901536-CE98CE4E-F8D0-4128-B890-7FE0F1F3D490Q38085032-51691D7D-4F6F-4384-AA04-1AF2BE72831FQ38257644-6E222068-203E-4C2D-8FB6-A1B9C6847D8DQ38262168-34DE8930-84F3-451F-8E11-7EC0F88182CEQ38271427-22B781B1-B380-454A-8B1B-C8C1AA2A78A0Q39260807-81F5FB79-1433-41CD-A278-589466D45997Q45160730-055698C3-1A65-4C4A-986C-062F7ACB9903Q48095700-7786FD51-D9DF-4374-8260-4D2D215D4327Q55527154-323B100C-B6CE-495B-8AAF-5109C7A20FDFQ58314846-9B448B73-397C-4D4E-AA71-E9B550595A6BQ58823379-80B6D0D2-D42E-4848-B498-A1C9899435AA
P2860
Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Prolonged preseasonal treatmen ...... y increases clinical efficacy.
@ast
Prolonged preseasonal treatmen ...... y increases clinical efficacy.
@en
Prolonged preseasonal treatmen ...... y increases clinical efficacy.
@nl
type
label
Prolonged preseasonal treatmen ...... y increases clinical efficacy.
@ast
Prolonged preseasonal treatmen ...... y increases clinical efficacy.
@en
Prolonged preseasonal treatmen ...... y increases clinical efficacy.
@nl
prefLabel
Prolonged preseasonal treatmen ...... y increases clinical efficacy.
@ast
Prolonged preseasonal treatmen ...... y increases clinical efficacy.
@en
Prolonged preseasonal treatmen ...... y increases clinical efficacy.
@nl
P2093
P2860
P1433
P1476
Prolonged preseasonal treatmen ...... y increases clinical efficacy.
@en
P2093
J S Andersen
M A Calderon
S R Durham
P2860
P304
P356
10.1111/J.1398-9995.2007.01416.X
P577
2007-08-01T00:00:00Z